[Myelomonocytic leukemia: clinical, cytological, and cytogenetic studies of acute, subacute, and chronic forms (author's transl)].
44 patients suffering from myelomonocytic leukemia (MML) have been observed over the last four years. They have been subclassified in acute myelomonocytic and acute monoblastic leukemias (AMML, n = 12; AMoL, n = 10), subacute myelomonocytic leukemias (SMML, n = 13), and chronic myelomonocytic leukemias (CMML, n = 9) on the basis of bone marrow cytology(blast and promonocyte counts, maturation of granulopoesis) and cytochemical findings (peroxydase and unspecific esterase reaction). This subclassification has been proved to be of prognostic relevance by its good correlation with the mean survival times (AMML : 4.5 months, AMoL : 2.4 months, SMML : 8 months, CMML : 18 months). The acute forms have been treated in general with combined cytostatic chemotherapy, whereas SMML and CMML have been treated this way only in case of progression to an acute phase. These progressions to an AMML have been observed more often and earlier in subacute forms than in chronic forms. The diagnosis of SMML and CMML is supported by the finding of sea-blue histiocytes in the bone marrow, increased lysozyme levels in serum and urine and by the absence of the Philadelphia-Chromosome.
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D001856:Bone Marrow Examination; D002908:Chronic Disease; D005260:Female; D006644:Histiocytes; D006801:Humans; D007948:Leukemia, Monocytic, Acute / Q000175:diagnosis; D007951:Leukemia, Myeloid / Q000175:diagnosis* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009113:Muramidase / Q000097:blood / Q000652:urine; D011379:Prognosis
D009113:Muramidase
Mayo Clin Proc. 1971 Jan;46(1):52-5
5100991
Am J Med. 1969 Nov;47(5):785-96
5260581
Klin Wochenschr. 1969 Jul 15;47(14):778-84
5266635
Presse Med. 1970 Feb 14;78(8):359-64
5264816
Br J Cancer. 1973 Mar;27(3):191-202
4571665
Acta Pathol Microbiol Scand. 1968;72(3):360-6
5239982
Br J Haematol. 1976 Jan;32(1):1-7
1063030
Lancet. 1965 Aug 28;2(7409):444-5
14348609
N Engl J Med. 1970 Aug 27;283(9):456-9
5270611
Br J Haematol. 1976 Aug;33(4):451-8
188440
Lancet. 1973 Feb 17;1(7799):375
4121970
Blood. 1971 Feb;37(2):131-5
5549193
Blood. 1969 Feb;33(2):268-73
5250467
Med Klin. 1977 Apr 15;72(15):642-9
266111
N Engl J Med. 1964 Feb 6;270:269-74
14074651
J Natl Cancer Inst. 1962 Nov;29:911-31
13939164
Stain Technol. 1962 Jan;37:17-20
13921436
Ann Inst Pasteur (Paris). 1971 Mar;120(3):337-55
4931646
Cancer. 1971 May;27(5):1218-20
4932008
Acta Histochem Suppl. 1977;Suppl 18:203-8
45628
Chromosoma. 1970;30(2):215-27
4193398
Acta Haematol. 1971;45(4):209-17
4105996
Cancer. 1971 May;27(5):1221-30
5281246
Nouv Rev Fr Hematol Blood Cells. 1976;17(1-2):109-24
1069970
Br J Haematol. 1964 Oct;10:551-66
14218457
Sem Hop. 1972 Jun 8;48(27):1943-56
4340963
Cancer. 1976 Aug;38(2):762-9
1067892
Blood. 1968 Nov;32(5):755-66
5246595
Blood. 1974 Mar;43(3):341-50
4521369
Ann Intern Med. 1970 Feb;72(2):175-82
5263036
Am J Med. 1956 Apr;20(4):588-602
13302235
J Pediatr. 1975 Feb;86(2):221-4
1053930
Blood. 1955 Oct;10 (10 ):1023-9
13260361
Klin Wochenschr. 1961 Dec 1;39:1220-7
14466209
Br J Haematol. 1972 Jun;22(6):773-82
4504518
Cancer. 1971 Jan;27(1):176-85
5275926
Semin Hematol. 1974 Apr;11(2):129-39
4136589
Am J Med. 1974 Dec;57(6):853-61
4530626
Br J Haematol. 1975 Jul;30(3):289-302
1059474
Am J Med. 1973 Oct;55(3):542-8
4355172
Myelomonozytäre Leukämie: Klinische, zytologische und zytogenetische Studien bei akuten, subakuten und chronischen Verlaufsformen.